| Summary of results B: Participants with at least one adverse event | |||||
|---|---|---|---|---|---|
| Dose | Studies | Participants | Etodolac (%) | Placebo (%) | NNH (95%CI) |
| 50 mg | 4 | 320 | 8 | 6 | not calculated |
| 100 mg | 5 | 459 | 11 | 7 | not calculated |
| 200 mg | 7 | 633 | 22 | 17 | not calculated |
| 400 mg | 4 | 310 | 28 | 34 | not calculated |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.